{"id":1042859,"date":"2021-11-19T17:39:12","date_gmt":"2021-11-19T22:39:12","guid":{"rendered":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/uncategorized\/morgan-stanley-stick-to-their-buy-rating-for-stryker-corporation-by-investing-com-investing-com\/"},"modified":"2021-11-19T17:39:12","modified_gmt":"2021-11-19T22:39:12","slug":"morgan-stanley-stick-to-their-buy-rating-for-stryker-corporation-by-investing-com-investing-com","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/neurotechnology\/morgan-stanley-stick-to-their-buy-rating-for-stryker-corporation-by-investing-com-investing-com\/","title":{"rendered":"Morgan Stanley Stick to Their Buy Rating for Stryker Corporation By Investing.com &#8211; Investing.com"},"content":{"rendered":"<p><p> Morgan Stanley  (NYSE:) analyst Drew Ranieri maintained a Buy rating on  Stryker  Corporation (NYSE:) on Friday, setting a price target of $305, which is approximately 17.44% above the present share price of $259.7.<\/p>\n<p>Ranieri expects Stryker Corporation to post earnings per share (EPS) of $1.17 for the fourth quarter of 2021.<\/p>\n<p>The current consensus among 10 TipRanks analysts is for a Moderate Buy rating of shares in Stryker, with an average price target of $287.57.The analysts price targets range from a high of $302 to a low of $250.<\/p>\n<p>In its latest earnings report, released on 09\/30\/2021, the company reported a quarterly revenue of $4.16 billion and a net profit of $590 million. The company's market cap is $97.97 billion.<\/p>\n<p>According to TipRanks.com, Morgan Stanley analyst Drew Ranieri is currently ranked with 1 stars on a 0-5 stars ranking scale, with an average return of -0.9% and a 40.00% success rate.<\/p>\n<p>Michigan-based Stryker Corp. was founded in 1941. The company provides medical technology products and services. It operates its business through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine.<\/p>\n<p>Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy\/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>See the original post here:<\/p>\n<p><a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.investing.com\/news\/morgan-stanley-stick-to-their-buy-rating-for-stryker-corporation-2685496\" title=\"Morgan Stanley Stick to Their Buy Rating for Stryker Corporation By Investing.com - Investing.com\">Morgan Stanley Stick to Their Buy Rating for Stryker Corporation By Investing.com - Investing.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Morgan Stanley (NYSE:) analyst Drew Ranieri maintained a Buy rating on Stryker Corporation (NYSE:) on Friday, setting a price target of $305, which is approximately 17.44% above the present share price of $259.7. Ranieri expects Stryker Corporation to post earnings per share (EPS) of $1.17 for the fourth quarter of 2021.  <a href=\"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/neurotechnology\/morgan-stanley-stick-to-their-buy-rating-for-stryker-corporation-by-investing-com-investing-com\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[187755],"tags":[],"class_list":["post-1042859","post","type-post","status-publish","format-standard","hentry","category-neurotechnology"],"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/1042859"}],"collection":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/comments?post=1042859"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/1042859\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/media?parent=1042859"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/categories?post=1042859"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/tags?post=1042859"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}